Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases

2018 ◽  
Vol 79 (5) ◽  
pp. 316-318 ◽  
Author(s):  
Robbert W. K. Borgemeester ◽  
Teus van Laar ◽  
Marie L. A. Schuttelaar
2018 ◽  
Vol 25 (7) ◽  
pp. 1726-1730 ◽  
Author(s):  
Mohammad Solduzian ◽  
Saeed Anvari ◽  
Hamidreza Taghvaye Masoumi ◽  
Farhad Shahi ◽  
Zahra Jahangard-Rafsanjani

Background Severe hypersensitivity reaction is a dangerous adverse drug reaction in patients receiving cetuximab. It requires drug discontinuation and medical management. Case description A 48-year-old man, previously diagnosed with metastatic colorectal cancer, was admitted for therapy continuation. During the first infusion of cetuximab, the patient experienced acute signs of hypersensitivity reactions. The treatment team decided to administer cetuximab employing the desensitization protocol. Conclusions This study reports a severe hypersensitivity reaction to cetuximab in an adult patient with colorectal cancer. This patient was successfully managed with a new safe and rapid desensitization protocol.


2010 ◽  
Vol 38 (5) ◽  
pp. 447-455
Author(s):  
Fares SALAMEH ◽  
Martine Szyper KRAVITZ ◽  
Aviv BARZILAI ◽  
Sharon BAUM ◽  
Yehuda SHOENFELD ◽  
...  

2008 ◽  
Vol 27 (1) ◽  
pp. 5-9 ◽  
Author(s):  
Xingdong Jian ◽  
Guangran Guo ◽  
Yanjun Ruan ◽  
Dawei Lin ◽  
Xingfu Li

Sign in / Sign up

Export Citation Format

Share Document